510(k) Report

FDA applicant

Abbott

St. Paul, MN14 decisions2018–20264 recalls

FDA records 14 decisions for Abbott (St. Paul, MN) from 2018 to 2026: 13 510(k) clearances and 1 original PMA approval. Most are in product codes DQK (Computer, Diagnostic, Programmable) and MXC (Recorder, Event, Implantable Cardiac, (Without…). Since 2016 its 510(k)s took a median of 30 days from receipt to decision, against 95 for FDA’s reviews in the same codes and years. Its devices cite 14 predicates, 1 of them its own earlier devices. 4 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Abbott’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2018: 22019: 42021: 22022: 22024: 12025: 12026 (partial year): 2
2018high 4 (2019) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

1in 2024

2021: 32024: 1
2018high 3 (2021) · low 0 (2018)2026

Class I Class II/III not classified

FIG. 1 — Abbott by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Abbott’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Abbott”

FDA records each applicant name separately; these may or may not be the same firm.